BlackRock
OKUR

BlackRock’s OnKure Therapeutics OKUR Stock Holding History

BlackRock’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$205K Sell
49,587
-3,091
-6% -$9.54K ﹤0.01% 4761
2025
Q4 		$153K Sell
52,678
-512,158
-91% -$1.53M ﹤0.01% 4795
2025
Q3 		$1.55M Buy
564,836
+33
+0% +$82 ﹤0.01% 4171
2025
Q2 		$1.35M Buy
564,803
+475,822
+535% +$1.25M ﹤0.01% 4163
2025
Q1 		$383K Sell
88,981
-5,036
-5% -$28.3K ﹤0.01% 4463
2024
Q4 		$809K Buy
94,017
+71,884
+325% +$1.09M ﹤0.01% 4274
2024
Q3 		$376K Sell
22,133
-7,232
-25% -$107K ﹤0.01% 4395
2024
Q2 		$443K Sell
29,365
-70,001
-70% -$1.19M ﹤0.01% 4373
2024
Q1 		$1.65M Buy
99,366
+1,036
+1% +$17.1K ﹤0.01% 4066
2023
Q4 		$1.57M Buy
98,330
+36,448
+59% +$2.27M ﹤0.01% 4122
2023
Q3 		$4.71M Buy
61,882
+16,189
+35% +$1.1M ﹤0.01% 3676
2023
Q2 		$3M Buy
45,693
+43,329
+1,833% +$3.49M ﹤0.01% 3890
2023
Q1 		$141K Sell
2,364
-66
-3% -$2.39K ﹤0.01% 4882
2022
Q4 		$56.6K Buy
2,430
+50
+2% +$1.33K ﹤0.01% 5192
2022
Q3 		$80K Buy
2,380
+79
+3% +$2.59K ﹤0.01% 5241
2022
Q2 		$61K Sell
2,301
-29,402
-93% -$684K ﹤0.01% 5374
2022
Q1 		$932K Buy
31,703
+15
+0% +$839 ﹤0.01% 4692
2021
Q4 		$2.71M Buy
31,688
+2,260
+8% +$166K ﹤0.01% 4277
2021
Q3 		$2.19M Buy
29,428
+446
+2% +$37.9K ﹤0.01% 4285
2021
Q2 		$2.7M Buy
+28,982
New +$3.23M ﹤0.01% 4140

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock's OKUR Position: Q1 2026 in Review

BlackRock reduced its OnKure Therapeutics (OKUR) stake by 5.9% in Q1 2026, selling an estimated $9.54K and leaving 49,587 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #4761.

BlackRock first reported a position in OKUR in Q2 2021 and has held it in 20 quarters since. The position peaked at $4.71M in Q3 2023. 51 funds tracked by Wall St. Rank hold OKUR as of Q1 2026.

  • BlackRock held 49,587 shares of OnKure Therapeutics worth $205K as of Q1 2026.
  • BlackRock sold 3,091 OnKure Therapeutics shares in Q1 2026, an estimated $9.54K.
  • OnKure Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4761 holding.
  • BlackRock first reported a position in OnKure Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • BlackRock's OnKure Therapeutics position peaked at $4.71M in Q3 2023.
  • 51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.